News & Updates

Epilepsy patients with brain tumour may fare better with levetiracetam vs valproic acid

29 Mar 2021 by

Levetiracetam may be preferable to valproic acid for the first‐line treatment of epilepsy in patients with glioma, with an observational study showing that the former has a more favourable efficacy but similar level of toxicity.

Epilepsy patients with brain tumour may fare better with levetiracetam vs valproic acid

29 Mar 2021

Inverse association between carotenoids, breast cancer more pronounced in high-risk women

29 Mar 2021

Circulating carotenoids are inversely associated with the risk of breast cancer, and this is more evident in high-risk women, as defined by germline genetic makeup or mammographic density (MD), reports a recent study.

Inverse association between carotenoids, breast cancer more pronounced in high-risk women

29 Mar 2021

Sleep disruption, fatigue predict long-term risks of relapse, mortality after HCT

29 Mar 2021

Among patients who have undergone allogeneic haematopoietic stem cell transplantation (HCT), biobehavioural symptoms, such as sleep disruption and fatigue interference, may signal a heightened risk of relapse and mortality over 6 years following HCT, according to a study.

Sleep disruption, fatigue predict long-term risks of relapse, mortality after HCT

29 Mar 2021

AI learns to pinpoint cancer cells by their pH level, promises early cancer diagnosis

26 Mar 2021 by

A novel artificial intelligence (AI) system helps distinguish cancerous from healthy cells based on their acidity alone, paving the way for rapid, noninvasive single-cell classification that can facilitate early cancer diagnosis.

AI learns to pinpoint cancer cells by their pH level, promises early cancer diagnosis

26 Mar 2021

Margetuximab bests trastuzumab in advanced breast cancer

25 Mar 2021 by

Adding margetuximab – a novel chimeric Fc-engineered anti-ERBB2* antibody – to single-agent chemotherapy (CT) yielded better survival benefit and favourable safety compared with the trastuzumab-CT regimen for women with pretreated ERRB2-positive advanced breast cancer (ERRB2+ ABC), according to the initial results of the phase III SOPHIA trial.

Margetuximab bests trastuzumab in advanced breast cancer

25 Mar 2021

Early-life sugar, sugary drinks intake in adolescence may promote adenoma

24 Mar 2021

High intake of simple sugars and sugar-sweetened beverages during adolescence appears to contribute to an increased risk of conventional adenoma, especially rectal adenoma, a study has found.

Early-life sugar, sugary drinks intake in adolescence may promote adenoma

24 Mar 2021

Cabozantinib improves PFS, response in metastatic papillary RCC

23 Mar 2021 by

In patients with metastatic papillary renal cell carcinoma (PRCC), cabozantinib led to greater progression-free survival (PFS) and overall response rate (ORR) than sunitinib, results of the phase II SWOG 1500 study showed.

Cabozantinib improves PFS, response in metastatic papillary RCC

23 Mar 2021

Neoadjuvant chemotherapy for rectal cancer does not impair postoperative bowel function

23 Mar 2021

Neoadjuvant chemotherapy alone does not seem to trigger low anterior resection syndrome during rectal cancer treatment, a recent study has found.

Neoadjuvant chemotherapy for rectal cancer does not impair postoperative bowel function

23 Mar 2021

$Eribulin mesylate safe, effective in hormone-refractory, triple-negative breast cancers$

Eribulin mesylate safe, effective in hormone-refractory, triple-negative breast cancers

23 Mar 2021

Eribulin mesylate (EM) shows promise as a third-line chemotherapy option for patients with hormone-resistant or triple-negative breast cancer, reports a study.

Eribulin mesylate safe, effective in hormone-refractory, triple-negative breast cancers

23 Mar 2021

Second-line chemo improves survival in advanced biliary tract, gallbladder cancers

23 Mar 2021

Second-line chemotherapy may prolong the life of real-world patients with advanced biliary tract and gallbladder cancers and must therefore be provided to those who are potential candidates for chemotherapy, suggests a study.

Second-line chemo improves survival in advanced biliary tract, gallbladder cancers

23 Mar 2021

News & Updates

Filter by Specialty:

Specialty:

Epilepsy patients with brain tumour may fare better with levetiracetam vs valproic acid

Epilepsy patients with brain tumour may fare better with levetiracetam vs valproic acid

Inverse association between carotenoids, breast cancer more pronounced in high-risk women

Inverse association between carotenoids, breast cancer more pronounced in high-risk women

Sleep disruption, fatigue predict long-term risks of relapse, mortality after HCT

Sleep disruption, fatigue predict long-term risks of relapse, mortality after HCT

AI learns to pinpoint cancer cells by their pH level, promises early cancer diagnosis

AI learns to pinpoint cancer cells by their pH level, promises early cancer diagnosis

Margetuximab bests trastuzumab in advanced breast cancer

Margetuximab bests trastuzumab in advanced breast cancer

Early-life sugar, sugary drinks intake in adolescence may promote adenoma

Early-life sugar, sugary drinks intake in adolescence may promote adenoma

Cabozantinib improves PFS, response in metastatic papillary RCC

Cabozantinib improves PFS, response in metastatic papillary RCC

Neoadjuvant chemotherapy for rectal cancer does not impair postoperative bowel function

Neoadjuvant chemotherapy for rectal cancer does not impair postoperative bowel function

Eribulin mesylate safe, effective in hormone-refractory, triple-negative breast cancers

Eribulin mesylate safe, effective in hormone-refractory, triple-negative breast cancers

Second-line chemo improves survival in advanced biliary tract, gallbladder cancers

Second-line chemo improves survival in advanced biliary tract, gallbladder cancers